Herbalife Ltd.

Report azionario NYSE:HLF

Capitalizzazione di mercato: US$1.3b

Herbalife Crescita futura

Criteri Future verificati 3/6

Si prevede che Herbalife aumenterà gli utili e i ricavi rispettivamente del 37.2% e 2.6% all'anno, mentre si prevede che l'EPS crescerà del 36.1% all'anno.

Informazioni chiave

37.2%

Tasso di crescita degli utili

36.11%

Tasso di crescita dell'EPS

Personal Products crescita degli utili27.3%
Tasso di crescita dei ricavi2.6%
Rendimento futuro del capitale proprion/a
Copertura analitica

Low

Ultimo aggiornamento07 Aug 2026

Aggiornamenti recenti sulla crescita futura

Articolo di analisi • Aug 08

Herbalife Ltd. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Herbalife Ltd. ( NYSE:HLF ) came out with its second-quarter results last week, and we wanted to see how the business...

Recent updates

Seeking Alpha • Aug 17

Herbalife Ltd.: The Share Price Is Discounting Terminal Decline

Summary Herbalife Ltd. is rated a 'risky' Buy, with shares trading at a steep discount and the market pricing in an overly pessimistic perpetual decline. HLF posted four consecutive quarters of YoY net sales growth, driven mainly by a one-off India GST cut, while other regions showed mixed or declining volume trends. Strategic repositioning toward personalized nutrition and deleveraging efforts are underway, with net leverage reduced to 2.2x and $45M in annual cash interest savings unlocked. Despite risks from GLP-1 adoption, growth concentration, leverage, and regulatory exposure, the current price offers potential upside versus a base case fair value near $24. Read the full article on Seeking Alpha
Articolo di analisi • Aug 08

Herbalife Ltd. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Herbalife Ltd. ( NYSE:HLF ) came out with its second-quarter results last week, and we wanted to see how the business...
Aggiornamento narrativa • Aug 07

HLF: 2026 Guidance Execution And Margin Expansion Will Support Share Recovery

Analysts have trimmed their price target on Herbalife to $17 from $21, reflecting updated views on fair value, discount rate, revenue growth, profit margins and future P/E assumptions. What’s in the News for Herbalife Herbalife raised its full year 2026 net sales guidance to a range of 2.5% to 5.5% year over year, compared with its previous range of 1.5% to 5.5% year over year.
Aggiornamento narrativa • Jun 18

HLF: Execution On 2026 Guidance And Margins Will Drive Stock Rebound

Analysts have lifted their price target on Herbalife to about $18.33 from $17.50, citing updated assumptions around discount rates, expected revenue growth, profit margins, and future P/E multiples reflected in recent research. Analyst Commentary Recent research on Herbalife highlights a mix of optimism around execution and valuation, alongside ongoing caution about the company’s ability to sustain and convert growth assumptions into consistent earnings.
Aggiornamento narrativa • Jun 03

HLF: Refinancing And Margin Improvement Will Support Turnaround Despite Weak EBITDA Guidance

Narrative update on Herbalife Analysts have raised their price target on Herbalife by $2, citing research that points to updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. Analyst Commentary Bullish analysts raising their price target by US$2 are signaling a more constructive view on how Herbalife’s valuation lines up with its fundamentals.
Articolo di analisi • May 19

Investors Can Find Comfort In Herbalife's (NYSE:HLF) Earnings Quality

Investors were disappointed with the weak earnings posted by Herbalife Ltd. ( NYSE:HLF ). However, our analysis...
Aggiornamento narrativa • May 05

HLF: Mixed 2026 Guidance And Execution Outlook Will Shape Turnaround Prospects

Herbalife's analyst price target has been revised higher to $17.50 from $16.50, with analysts pointing to updated fair value assumptions and recent target increases at firms such as Citi, BofA and Mizuho following Q4 results and 2026 guidance. Analyst Commentary Recent research updates show a mix of optimism and caution around Herbalife, with price targets moving in different directions as analysts react to Q4 results, 2026 guidance and updated assumptions around execution and valuation.
Aggiornamento narrativa • Apr 20

HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum

Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.
Aggiornamento narrativa • Apr 06

HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery

Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.
Aggiornamento narrativa • Mar 23

HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures

Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.
Aggiornamento narrativa • Mar 09

HLF: 2026 Turnaround Hopes Will Confront Persistent Competitive And Fundamental Risks

The analyst price target for Herbalife has been raised by $1 to $9. Analysts point to largely in line Q4 results, new 2026 guidance, and a mix of Buy, Neutral, and Underperform views that reflect both perceived momentum and ongoing concerns around competition, fundamentals, and valuation.
Aggiornamento narrativa • Feb 23

HLF: Turnaround Will Be Driven By 2026 Guidance And Margin Recovery

Narrative Update: Herbalife The updated analyst fair value estimate for Herbalife has moved from $11 to $25, a shift analysts link to refreshed price targets in the $9 to $21 range, stronger Q4 commentary, improved margin assumptions, and a lower discount rate despite mixed views on long term growth and valuation risks. Analyst Commentary Recent Street research on Herbalife reflects a mix of views, but several bullish analysts have been willing to raise price targets or upgrade their stance following recent updates from the company.
Aggiornamento narrativa • Feb 08

HLF: Turnaround Hopes Under New Leadership Will Confront Compressed Sector Multiples

Narrative Update: Herbalife Analyst Price Target Move The blended analyst price target for Herbalife has moved higher, with recent increases such as Mizuho's lift to $13 and Maxim's initiation at $20. Analysts point to an ongoing turnaround, progress under new leadership, and a healthier long term profile for Herbalife's business model, while also noting continuing concerns about competition and broader macro uncertainty.
Aggiornamento narrativa • Jan 25

HLF: Recovery Story Under New Leadership Will Face Compressed Sector Multiples

Narrative Update on Herbalife The analyst price target for Herbalife has been revised higher to reflect an updated fair value of $8.00, a lower discount rate of 10.02%, and adjustments to revenue growth, profit margin, and future P/E assumptions, as analysts factor in recent target hikes, Buy initiations, and views of a continuing recovery path under new leadership. Analyst Commentary Recent Street research on Herbalife reflects a mix of optimism about a potential recovery and caution around execution and valuation risks.
Articolo di analisi • Jan 22

Herbalife Ltd. (NYSE:HLF) Shares Fly 27% But Investors Aren't Buying For Growth

Herbalife Ltd. ( NYSE:HLF ) shares have continued their recent momentum with a 27% gain in the last month alone. The...
Aggiornamento narrativa • Jan 11

HLF: Turnaround And Margin Recovery Under New Leadership Will Face Valuation Constraints

The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations. Analyst Commentary Recent research on Herbalife reflects a mix of optimism about the company’s turnaround efforts and caution about broader sector and macro headwinds.
Aggiornamento narrativa • Dec 25

HLF: Recovery Path Under New Leadership Will Likely Deliver Disappointing Multiple Expansion

Analysts have modestly raised their fair value estimate for Herbalife from approximately $9.67 to $12.00 per share, citing a lower perceived risk profile, steady growth and margin assumptions, and a more constructive view on future earnings multiples as fundamentals continue on a recovery path under new leadership. Analyst Commentary Analyst sentiment around Herbalife is gradually improving as execution under new leadership gains traction and forward growth expectations firm up, though views on the pace and durability of the recovery remain mixed.
Aggiornamento narrativa • Dec 11

HLF: Recovery Path Under New Leadership Will Likely Prove Overpriced

Analysts have modestly raised their price target on Herbalife to $11 from $10, citing a gradually lower perceived risk profile, steady long term growth and margin assumptions, and growing confidence that the company is on a recovery path under new leadership, with a potential return to volume growth by fiscal 2026. Analyst Commentary Bullish analysts point to the recent rating upgrade and price target increase as evidence that sentiment around Herbalife is gradually improving, with expectations that operational execution will support a more favorable risk and reward profile over the next several years.
Aggiornamento narrativa • Nov 27

HLF: Uncertainty Around CEO Transition Will Challenge Near-Term Momentum

Herbalife’s analyst price target has been raised to $11 from $10, as analysts point to recovering fundamentals and the company’s strategic leadership changes as promising signs for future growth. Analyst Commentary Analysts have recently weighed in on Herbalife, offering a mix of optimism about its improving fundamentals and some caution about ongoing risks.
Articolo di analisi • Nov 13

We Think That There Are Some Issues For Herbalife (NYSE:HLF) Beyond Its Promising Earnings

The market for Herbalife Ltd.'s ( NYSE:HLF ) stock was strong after it released a healthy earnings report last week...
Articolo di analisi • Oct 29

The Market Doesn't Like What It Sees From Herbalife Ltd.'s (NYSE:HLF) Earnings Yet

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
Articolo di analisi • Sep 26

At US$8.75, Is Herbalife Ltd. (NYSE:HLF) Worth Looking At Closely?

Herbalife Ltd. ( NYSE:HLF ), might not be a large cap stock, but it saw a decent share price growth of 11% on the NYSE...
Articolo di analisi • Jul 24

A Look At The Intrinsic Value Of Herbalife Ltd. (NYSE:HLF)

Key Insights The projected fair value for Herbalife is US$9.20 based on 2 Stage Free Cash Flow to Equity Herbalife's...
Articolo di analisi • Jun 25

There's No Escaping Herbalife Ltd.'s (NYSE:HLF) Muted Earnings Despite A 26% Share Price Rise

Those holding Herbalife Ltd. ( NYSE:HLF ) shares would be relieved that the share price has rebounded 26% in the last...
Articolo di analisi • May 28

Herbalife (NYSE:HLF) Hasn't Managed To Accelerate Its Returns

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Articolo di analisi • May 08

Herbalife's (NYSE:HLF) Earnings Offer More Than Meets The Eye

Herbalife Ltd.'s ( NYSE:HLF ) solid earnings announcement recently didn't do much to the stock price. We did some...
Articolo di analisi • Mar 13

Herbalife Ltd.'s (NYSE:HLF) Share Price Boosted 63% But Its Business Prospects Need A Lift Too

Herbalife Ltd. ( NYSE:HLF ) shares have had a really impressive month, gaining 63% after a shaky period beforehand. But...
Seeking Alpha • Feb 24

Herbalife: The Battleground Stock Is Showing Some Turnaround Potential

Summary Herbalife still operates in 95 countries using a direct selling and MLM model with six million independent distributors. Currently, HLF is facing declining sales volumes, which have been partly offset by price increases. However, it remains uncertain how sustainable this is in the long run. Post-FTC settlement, I think HLF has “sanitized” its business model, even though it has indeed made it more challenging to grow its MLM business. The good news is its focus. They have a mixed regional performance, in particular with China struggling while Asia Pacific stabilizes. Additionally, its recruitment and sales leaders numbers have been encouraging in Q4 and 2024. Based on EV/EBITDA metrics, HLF is undeniably still priced at a steep discount. However, at this point, I believe the risk-reward equation is more favorable for the bulls. Hence, I rate it a speculative “Buy” for the short term. Read the full article on Seeking Alpha

Previsioni di crescita degli utili e dei ricavi

NYSE:HLF - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20285,558373N/AN/A2
12/31/20275,390306N/AN/A3
12/31/20265,259165N/AN/A3
6/30/20265,201164322384N/A
3/31/20265,133240374447N/A
12/31/20255,038228253333N/A
9/30/20254,962321217305N/A
6/30/20254,929325171265N/A
3/31/20254,951280164272N/A
12/31/20244,993254163285N/A
9/30/20245,00187180312N/A
6/30/20245,04282156292N/A
3/31/20245,075137188325N/A
12/31/20235,062142223358N/A
9/30/20235,028186173315N/A
6/30/20235,042226156305N/A
3/31/20235,121252123268N/A
12/31/20225,204321196353N/A
9/30/20225,342305224384N/A
6/30/20225,477340244403N/A
3/31/20225,637398321481N/A
12/31/20215,803447309460N/A
9/30/20215,896483347487N/A
6/30/20215,986504400531N/A
3/31/20215,781474476597N/A
12/31/20205,542373517629N/A
9/30/20205,351356571673N/A
6/30/20205,074299624728N/A
3/31/20204,967260N/A561N/A
12/31/20194,877311N/A458N/A
9/30/20194,843303N/A440N/A
6/30/20194,842293N/A418N/A
3/31/20194,887311N/A531N/A
12/31/20184,892297N/A648N/A
9/30/20184,799184N/A696N/A
6/30/20184,641168N/A659N/A
3/31/20184,503211N/A572N/A
12/31/20174,428214N/A591N/A
9/30/20174,379377N/A522N/A
6/30/20174,416410N/A276N/A
3/31/20174,471249N/A402N/A
12/31/20164,488260N/A367N/A
9/30/20164,542245N/A385N/A
6/30/20164,523251N/A638N/A
3/31/20164,483357N/A609N/A
12/31/20154,469339N/A629N/A
9/30/20154,504358N/A555N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di HLF ( 37.2% all'anno) è superiore al tasso di risparmio ( 3.7% ).

Guadagni vs Mercato: Si prevede che gli utili di HLF ( 37.2% all'anno) cresceranno più rapidamente del mercato US ( 16.9% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di HLF cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di HLF ( 2.6% all'anno) crescerà più lentamente rispetto al mercato US ( 12.9% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di HLF ( 2.6% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di HLF è previsto essere elevato tra 3 anni

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/08/21 11:17
Prezzo dell'azione a fine giornata2026/08/21 00:00
Utili2026/06/30
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Herbalife Ltd. è coperta da 14 analisti. 3 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
John StaszakArgus Research Company
Meredith AdlerBarclays
Brian WangBarclays